The mechanisms of microgliosis and pain following peripheral nerve injury
暂无分享,去创建一个
[1] M. Woodroofe,et al. Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro , 1999, Journal of neuroscience research.
[2] T. Möller,et al. Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton , 1996, Neuroscience.
[3] N. Stella,et al. Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: Quantification of migration by a novel near‐infrared method , 2009, Glia.
[4] J. Loeb,et al. Neuregulin-ErbB Signaling Promotes Microglial Proliferation and Chemotaxis Contributing to Microgliosis and Pain after Peripheral Nerve Injury , 2010, The Journal of Neuroscience.
[5] J.L.O'L.,et al. Chemical Pathology of the Nervous System (Proceedings of the Third International Neurochemical Symposium held at Strasbourg, 1958) , 1962, Neurology.
[6] Jin Mo Chung,et al. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.
[7] R. von Bernhardi,et al. Modulation by Astrocytes of Microglial Cell-Mediated Neuroinflammation: Effect on the Activation of Microglial Signaling Pathways , 2007, Neuroimmunomodulation.
[8] G. Kreutzberg,et al. Inhibition of Posttraumatic Microglial Proliferation in a Genetic Model of Macrophage Colony‐Stimulating Factor Deficiency in the Mouse , 1994, The European journal of neuroscience.
[9] J. Deleo,et al. CNS‐infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection‐induced neuropathic pain , 2008, European journal of immunology.
[10] Atsushi Tokunaga,et al. Activating Transcription Factor 3 (ATF3) Induction by Axotomy in Sensory and Motoneurons: A Novel Neuronal Marker of Nerve Injury , 2000, Molecular and Cellular Neuroscience.
[11] S. Kohsaka,et al. Macrophage‐colony stimulating factor as an inducer of microglial proliferation in axotomized rat facial nucleus , 2010, Journal of neurochemistry.
[12] Kirk W. Johnson,et al. Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10 , 2005, The European journal of neuroscience.
[13] Maria Fitzgerald,et al. T-Cell Infiltration and Signaling in the Adult Dorsal Spinal Cord Is a Major Contributor to Neuropathic Pain-Like Hypersensitivity , 2009, The Journal of Neuroscience.
[14] G. Kreutzberg,et al. Displacement of synaptic terminals from regenerating motoneurons by microglial cells , 2004, Zeitschrift für Zellforschung und Mikroskopische Anatomie.
[15] O. Soehnlein,et al. Phagocyte partnership during the onset and resolution of inflammation , 2010, Nature Reviews Immunology.
[16] B. Trapp,et al. Evidence for synaptic stripping by cortical microglia , 2007, Glia.
[17] A. Eschalier,et al. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain , 1993, Pain.
[18] M. Etienne,et al. Phosphorylation of spinal N-methyl-d-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy. , 2011, European journal of pain.
[19] M. Malcangio,et al. The Liberation of Fractalkine in the Dorsal Horn Requires Microglial Cathepsin S , 2009, The Journal of Neuroscience.
[20] S. Ho,et al. Inhibition of p38 mitogen‐activated protein kinase attenuates interleukin‐1β‐induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord , 2005, Journal of neurochemistry.
[21] S. Koizumi,et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury , 2003, Nature.
[22] S. Nedergaard,et al. Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain , 2009, European journal of pain.
[23] K. Jacobson,et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis , 2007, Nature.
[24] Clifford J. Woolf,et al. Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity , 2007, The Journal of Neuroscience.
[25] F. Ginhoux,et al. Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.
[26] V. Perry. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation , 1998, Journal of Neuroimmunology.
[27] Stephen P. H. Alexander,et al. Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain , 2009, Molecular pain.
[28] I. Maridonneau-Parini,et al. Complement Receptor 3 (CD11b/CD18) Mediates Type I and Type II Phagocytosis During Nonopsonic and Opsonic Phagocytosis, Respectively1 , 2002, The Journal of Immunology.
[29] Y. Imai,et al. Extracellular ATP or ADP Induce Chemotaxis of Cultured Microglia through Gi/o-Coupled P2Y Receptors , 2001, The Journal of Neuroscience.
[30] Kazuhide Inoue,et al. Extracellular ATP Triggers Tumor Necrosis Factor‐α Release from Rat Microglia , 2000 .
[31] S. Maier,et al. Enduring Reversal of Neuropathic Pain by a Single Intrathecal Injection of Adenosine 2A Receptor Agonists: A Novel Therapy for Neuropathic Pain , 2009, The Journal of Neuroscience.
[32] R. P. Landry,et al. Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation , 2009, Molecular pain.
[33] Kazuhide Inoue,et al. Involvement of P2X4 and P2Y12 receptors in ATP‐induced microglial chemotaxis , 2007, Glia.
[34] John Grist,et al. CCL2 is a key mediator of microglia activation in neuropathic pain states , 2009, European journal of pain.
[35] V. Tawfik,et al. Neuregulin 1 is a pronociceptive cytokine that is regulated by progesterone in the spinal cord: Implications for sex specific pain modulation , 2008, European journal of pain.
[36] K. Schroder,et al. Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.
[37] P. Mcgeer,et al. Brain microglia constitutively express beta-2 integrins. , 1990, Journal of neuroimmunology.
[38] J. Sagen,et al. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis , 2001, Journal of Neuroimmunology.
[39] Yang Ping,et al. Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model , 2010, Molecular pain.
[40] M. Svensson,et al. Synaptic Density of Axotomized Hypoglossal Motorneurons Following Pharmacological Blockade of the Microglial Cell Proliferation , 1993, Experimental Neurology.
[41] V. Perry,et al. Turnover of resident microglia in the normal adult mouse brain , 1992, Neuroscience.
[42] H. Tozaki-Saitoh,et al. Nerve injury‐activated microglia engulf myelinated axons in a P2Y12 signaling‐dependent manner in the dorsal horn , 2010, Glia.
[43] R. Ji,et al. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine , 2007, Brain, Behavior, and Immunity.
[44] Christopher B Wilson,et al. Regulation of interferon-gamma during innate and adaptive immune responses. , 2007, Advances in immunology.
[45] R. Ji,et al. Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord , 2008, The Journal of Neuroscience.
[46] G. Wasner,et al. Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[47] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[48] W. Gan,et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides , 2006, Nature Neuroscience.
[49] J. Deleo,et al. Spinal Microglial and Perivascular Cell Cannabinoid Receptor Type 2 Activation Reduces Behavioral Hypersensitivity without Tolerance after Peripheral Nerve Injury , 2008, Anesthesiology.
[50] B. Rollins,et al. Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.
[51] J. Deleo,et al. Minocycline decreases in vitro microglial motility, β1‐integrin, and Kv1.3 channel expression , 2007, Journal of neurochemistry.
[52] J. Loeb,et al. Following Nerve Injury Neuregulin-1 Drives Microglial Proliferation and Neuropathic Pain via the MEK/ERK Pathway , 2011, Glia.
[53] Andrew R Segerdahl,et al. Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. , 2007, Brain : a journal of neurology.
[54] P. Rakić,et al. Transganglionic degenerative atrophy in the substantia gelatinosa of the spinal cord after peripheral nerve transection in rhesus monkeys , 1987, Cell and Tissue Research.
[55] J. Deleo,et al. Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat , 2006, Neuroscience Letters.
[56] C. Woolf,et al. p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain , 2003, The Journal of Neuroscience.
[57] L. Mei,et al. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia , 2008, Nature Reviews Neuroscience.
[58] K. Schroder,et al. Interferon- : an overview of signals, mechanisms and functions , 2004 .
[59] M. Etienne,et al. Diabetes-Induced Mechanical Hyperalgesia Involves Spinal Mitogen-Activated Protein Kinase Activation in Neurons and Microglia via N-Methyl-D-aspartate-Dependent Mechanisms , 2006, Molecular Pharmacology.
[60] S. Maier,et al. Intrathecal HIV-1 Envelope Glycoprotein gp120 Induces Enhanced Pain States Mediated by Spinal Cord Proinflammatory Cytokines , 2001, The Journal of Neuroscience.
[61] S. Beggs,et al. Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury , 2007, Brain, Behavior, and Immunity.
[62] N. Calcutt,et al. Activation of p38 mitogen‐activated protein kinase in spinal microglia is a critical link in inflammation‐induced spinal pain processing , 2003, Journal of neurochemistry.
[63] L. Lao,et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia , 2005, Pain.
[64] S. Maier,et al. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions , 2004, The European journal of neuroscience.
[65] J. Deleo,et al. Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy , 2003, Journal of Pharmacology and Experimental Therapeutics.
[66] Ji Zhang,et al. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain , 2008, PAIN®.
[67] P. Ji,et al. Corticotropin‐releasing hormone induces proliferation and TNF‐α release in cultured rat microglia via MAP kinase signalling pathways , 2002, Journal of neurochemistry.
[68] M. Rudin,et al. Glial cell proliferation in the spinal cord after dorsal rhizotomy or sciatic nerve transection in the adult rat , 2000, Experimental Brain Research.
[69] V. Perry,et al. Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.
[70] P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways , 2010, Journal of neurochemistry.
[71] Ping-Heng Tan,et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain , 2008, Nature Medicine.
[72] C. Coe,et al. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients , 2008, Journal of Neuroimmunology.
[73] Hosung Jung,et al. Chemokines and the pathophysiology of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.
[74] John C. Lee,et al. Extracellular Signal-Regulated Kinase and p38 Subgroups of Mitogen-Activated Protein Kinases Regulate Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-α Gene Expression in Endotoxin-Stimulated Primary Glial Cultures , 1998, The Journal of Neuroscience.
[75] John D. Lambris,et al. The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.
[76] M. Malcangio,et al. Gabapentin reverses microglial activation in the spinal cord of streptozotocin‐induced diabetic rats , 2009, European journal of pain.
[77] H. Neumann,et al. Microglial clearance function in health and disease , 2009, Neuroscience.
[78] S. Rivest,et al. Bone-marrow-derived microglia: myth or reality? , 2008, Current opinion in pharmacology.
[79] Ronald Dubner,et al. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury , 1990, Pain.
[80] N. Carruthers,et al. Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain , 2005, The Journal of Neuroscience.
[81] M. Svensson,et al. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat , 1993, Experimental Brain Research.
[82] M. Weinstock,et al. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats , 2003, Experimental Neurology.
[83] R. Lecomte,et al. Behavioral, Medical Imaging and Histopathological Features of a New Rat Model of Bone Cancer Pain , 2010, PloS one.
[84] S. Papson,et al. “Model” , 1981 .
[85] Gary J. Bennett,et al. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction , 2006, Pain.
[86] M. Fitzgerald,et al. Brief, low frequency stimulation of rat peripheral C-fibres evokes prolonged microglial-induced central sensitization in adults but not in neonates , 2009, PAIN®.
[87] S. Koizumi,et al. Activation of p38 mitogen‐activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury , 2004, Glia.
[88] p38 MAPK, microglial signaling, and neuropathic pain , 2007, Molecular pain.
[89] H. Zeilhofer. Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microglia. , 2008, International immunopharmacology.
[90] P. Mantyh,et al. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain , 2005, Experimental Neurology.
[91] Kazuhide Inoue,et al. Purinergic systems in microglia , 2008, Cellular and Molecular Life Sciences.
[92] H. Kettenmann,et al. Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.
[93] F. Rossi,et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.
[94] R. Gross,et al. Adenosine A2A receptor mediates microglial process retraction , 2009, Nature Neuroscience.
[95] A. Todd,et al. Loss of Neurons from Laminas I-III of the Spinal Dorsal Horn Is Not Required for Development of Tactile Allodynia in the Spared Nerve Injury Model of Neuropathic Pain , 2005, The Journal of Neuroscience.
[96] S. Akira,et al. THIS ARTICLE HAS BEEN RETRACTED: Toll‐like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury , 2008, Journal of neurochemistry.
[97] Anirban Basu,et al. Inflammasome signaling at the heart of central nervous system pathology , 2010, Journal of neuroscience research.
[98] J. Antel,et al. TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1 , 2005, The Journal of Immunology.
[99] O. Sasso,et al. Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor , 2010, Glia.
[100] R. Myers,et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury , 2001, Neuroreport.
[101] J. Deleo,et al. The Effect of Site and Type of Nerve Injury on Spinal Glial Activation and Neuropathic Pain Behavior , 1999, Experimental Neurology.
[102] S. McMahon,et al. P2X7-Dependent Release of Interleukin-1β and Nociception in the Spinal Cord following Lipopolysaccharide , 2010, The Journal of Neuroscience.
[103] G. Bennett,et al. The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries , 2011, Neuroscience.
[104] I. Obrosova. Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments , 2009, Neurotherapeutics.
[105] S. Talbot,et al. Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy , 2010, Journal of Neuroinflammation.
[106] S. Opal,et al. Anti-inflammatory cytokines. , 2000, Chest.
[107] H. Boddeke,et al. Neuronal CCL21 up‐regulates microglia P2X4 expression and initiates neuropathic pain development , 2011, The EMBO journal.
[108] S. Maier,et al. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine , 2005, The European journal of neuroscience.
[109] Kirk W. Johnson,et al. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats , 2007, Brain, Behavior, and Immunity.
[110] P. Daull,et al. Inhibition of Type 1 Diabetic Hyperalgesia in Streptozotocin-Induced Wistar versus Spontaneous Gene-Prone BB/Worchester Rats: Efficacy of a Selective Bradykinin B1 Receptor Antagonist , 2005, Journal of neuropathology and experimental neurology.
[111] J. Deleo,et al. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[112] Charles N Serhan,et al. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions , 2010, Nature Medicine.
[113] H. Tozaki-Saitoh,et al. P2Y12 Receptors in Spinal Microglia Are Required for Neuropathic Pain after Peripheral Nerve Injury , 2008, The Journal of Neuroscience.
[114] H. Shimoyama,et al. IFN-γ receptor signaling mediates spinal microglia activation driving neuropathic pain , 2009, Proceedings of the National Academy of Sciences.
[115] T. Schall,et al. Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.
[116] R. Schwartzman,et al. Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome , 2009, Brain, Behavior, and Immunity.
[117] S. Bevan,et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.
[118] F. Helmchen,et al. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.
[119] Erin R. Reichenberger,et al. Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome , 2007, Brain, Behavior, and Immunity.
[120] A. Sauter,et al. Ischemia‐induced neuronal expression of the microglia attracting chemokine secondary lymphoid‐tissue chemokine (SLC) , 2001, Glia.
[121] Gary J. Bennett,et al. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.
[122] Andrew S.C. Rice,et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy , 2007, PAIN®.
[123] C. Woolf,et al. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model , 2005, Pain.
[124] H. Kettenmann,et al. Purinergic signaling and microglia , 2006, Pflügers Archiv.
[125] P. Mcgeer,et al. Brain microglia constitutively express β-2 integrins , 1990, Journal of Neuroimmunology.
[126] B. McEwen,et al. Acute in vivo exposure to interferon-γ enables resident brain dendritic cells to become effective antigen presenting cells , 2009, Proceedings of the National Academy of Sciences.
[127] C. D. Palmer,et al. Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain , 2009, European journal of immunology.
[128] D. Coyle,et al. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior , 1998, Glia.
[129] C. Chen,et al. Chronic Intrathecal Infusion of Minocycline Prevents the Development of Spinal-Nerve Ligation-Induced Pain in Rats , 2007, Regional Anesthesia & Pain Medicine.
[130] J. Mudgett,et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[131] C. Gravel,et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.
[132] R. Maki,et al. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. , 1999, Journal of immunology.
[133] S. Koizumi,et al. Mechanisms underlying extracellular ATP‐evoked interleukin‐6 release in mouse microglial cell line, MG‐5 , 2001, Journal of neurochemistry.
[134] W. Hickey,et al. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat , 1997, Journal of Neuroimmunology.
[135] G. Y. Wong,et al. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells , 2007, Experimental Neurology.
[136] H. Tozaki-Saitoh,et al. Pain and purinergic signaling , 2010, Brain Research Reviews.
[137] S. Maier,et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation , 2005, Pain.
[138] Osamu Yoshie,et al. Chemokine/chemokine receptor nomenclature. , 2003, Cytokine.
[139] G. Núñez,et al. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis , 2009, Nature Immunology.
[140] S. Akira,et al. A Critical Role of Toll-like Receptor 2 in Nerve Injury-induced Spinal Cord Glial Cell Activation and Pain Hypersensitivity* , 2007, Journal of Biological Chemistry.
[141] I. Decosterd,et al. Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury , 2009, Molecular pain.
[142] Y. Nakata,et al. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. , 2000, Journal of neurochemistry.
[143] M. Pauza,et al. Direct Role of Streptozotocin in Inducing Thermal Hyperalgesia by Enhanced Expression of Transient Receptor Potential Vanilloid 1 in Sensory Neurons , 2008, Molecular Pharmacology.
[144] C. Colton,et al. Chemotaxis by a CNS macrophage, the microglia , 1990, Journal of neuroscience research.
[145] H. Ueno,et al. Activation of dorsal horn microglia contributes to diabetes‐induced tactile allodynia via extracellular signal‐regulated protein kinase signaling , 2008, Glia.
[146] F. D’Acquisto,et al. Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells , 2011, Journal of Neuroimmunology.
[147] C. Woolf,et al. Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.
[148] Sunhee C. Lee,et al. Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Signaling and Microglial Proliferation by Anti-CD45RO: Role of Hck Tyrosine Kinase and Phosphatidylinositol 3-Kinase/Akt1 , 2005, The Journal of Immunology.
[149] S. Beggs,et al. P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase Activation , 2009, The Journal of Neuroscience.
[150] J. Deleo,et al. The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents , 2002, Journal of Neuroimmunology.
[151] Y. de Koninck,et al. Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain , 2007, The Journal of Neuroscience.
[152] A. Mildner,et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions , 2007, Nature Neuroscience.
[153] De-sheng Wang,et al. Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes , 2011, Brain Research.
[154] H. Boddeke,et al. Vesicle-Mediated Transport and Release of CCL21 in Endangered Neurons: A Possible Explanation for Microglia Activation Remote from a Primary Lesion , 2005, The Journal of Neuroscience.
[155] S. Miller,et al. Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs1 , 2004, The Journal of Immunology.
[156] S. McMahon,et al. Rapid co‐release of interleukin 1β and caspase 1 in spinal cord inflammation , 2006, Journal of neurochemistry.
[157] H. Baba,et al. Visualization of the cervical spinal cord with FDG and high-resolution PET. , 1998, Journal of computer assisted tomography.
[158] G. Dienel,et al. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats , 2006, Neurobiology of Disease.